CN Stock MarketDetailed Quotes

688428 InnoCare Pharma

Watchlist
  • 12.28
  • -0.41-3.23%
Market Closed Dec 31 15:00 CST
21.64BMarket Cap-57.65P/E (TTM)

InnoCare Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InnoCare Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 275.813M --
-- 2024/Q4 -- / 310.303M --
-- 2024/Q3 278.010M / 288.000M --
-- 2024/Q2 251.176M / 196.275M --
May 14, 2024 2024/Q1 165.824M / 181.644M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 275.813M--
--2024/Q4-- / 310.303M--
--2024/Q3278.010M / 288.000M--
--2024/Q2251.176M / 196.275M--
May 14, 20242024/Q1165.824M / 181.644M--

Unlock Free Earnings Estimates

InnoCare Pharma Earnings Reports

  • Nuochengjianhua Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Nov 12, 2024 00:00

  • Innocare Pharmaceuticals Co., Ltd. 2024 Half-year Report

    Aug 21, 2024 00:00

  • InnoCare Pharma: Announcement of midterm performance for the six months ending on June 30, 2024.

    Aug 21, 2024 00:00

  • Summary of the 2024 semi-annual report of innocare Pharmaceuticals Co., Ltd.

    Aug 21, 2024 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 1, 2025

    Buy

    • Strong Buy

      50.00%

    • Buy

      37.50%

    • Hold

      12.50%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme AH Stocks
    AH Stocks
    Intraday-0.92%
    Innovative Drugs
    Innovative Drugs
    Intraday-1.65%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday-1.72%